title: Is there an association between inappropriate prescription drug use and adherence in discharged elderly patients?
abstract: BACKGROUND
  Inappropriate prescription drug (IPD) use is very common among older patients. However, its impact on medication continuity and adherence after hospitalization has not been researched, with little known regarding readmissions and mortality.
  
  
  OBJECTIVE
  To investigate the prevalence and clinical characteristics of patients discharged with IPDs and examine whether use of these drugs is related to medication continuity and adherence 1 month postdischarge as well as to readmissions and mortality 3 months postdischarge.
  
  
  METHODS
  Clinical and demographic data, postdischarge medication modification, and adherence were prospectively obtained on interview of 212 unselected elderly (aged > or = 65 y) patients or, if necessary, their caregivers. Nonadherence was defined as the percentage of drug doses less than or equal to 70% or greater than or equal to 110%. Medication appropriateness was assessed retrospectively using the Beers' criteria.
  
  
  RESULTS
  Use of IPDs occurred in 43.5% and 44.4% of patients on admission and discharge, respectively. At discharge, the numbers of IPDs and prescribed drugs were correlated (R = 0.39; p < 0.01). No relationship was found between IPDs at discharge and age, sex, functional and cognitive status, number of chronic diseases, and reason for admission. Sixty percent of patients who were nonadherent to at least one drug had at least one IPD, compared with 37.4% of the adherent patients (p = 0.008). Nonadherence to at least one drug increased as the number of IPDs on discharge increased (p = 0.004). No relationship was found between IPD use and postdischarge medication modifications, readmissions, and mortality.
  
  
  CONCLUSIONS
  A high number of hospitalized elderly patients are discharged with IPDs that are directly correlated with the number of prescribed drugs at discharge and postdischarge nonadherence. Further studies are needed to assess the impact of postdischarge IPD use on health outcome, and healthcare providers should work to decrease its prevalence.
authors.affiliation: Pharmacy Services, Rabin Medical Center, Campus Beilinson, Sackler School of Medicine, Tel Aviv University, Petach Tikvah, Israel.
authors.forename: Nariman
authors.initials: N
authors.lastname: Mansur
authors.forename: Avraham
authors.initials: A
authors.lastname: Weiss
authors.forename: Yichayaou
authors.initials: Y
authors.lastname: Beloosesky
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D010351:Patient Discharge; D010359:Patient Readmission; D055553:Prescription Drugs / Q000009:adverse effects*; D011446:Prospective Studies; D012189:Retrospective Studies; D016903:Drug Monitoring
chemical_list: D055553:Prescription Drugs